Berenberg analyst Harry Gillis initiated coverage of Tecan (TCHBF) with a Buy rating and CHF 220 price target Tecan is a high-quality Swiss provider of life sciences and diagnostic lab automation equipment and medical device manufacturing, the analyst tells investors in a research note. The firm says the company is well positioned to achieve mid- to high-single-digit medium-term revenue growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCHBF: